Canada vs Germany: Death rate from Alzheimer's
Canada
80.69 deaths per 100,000 people
in 2021
Germany
79.01 deaths per 100,000 people
in 2021
Canada rank
10th
Germany rank
11th
Death rate from Alzheimer's over time
- Canada
- Germany
How they compare
Canada currently reports 80.69 deaths per 100,000 people against 79.01 deaths per 100,000 people in Germany, a difference of 1.68 deaths per 100,000 people.
Across all 22 years both countries report, Canada has been ahead every year.
Canada ranks 10th and Germany ranks 11th of 194 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Germany | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.89 deaths per 100,000 people | 13.94 deaths per 100,000 people | 26.95 deaths per 100,000 people | Canada |
| 2010s | 69.92 deaths per 100,000 people | 51.93 deaths per 100,000 people | 17.99 deaths per 100,000 people | Canada |
| 2020s | 80.54 deaths per 100,000 people | 78.84 deaths per 100,000 people | 1.69 deaths per 100,000 people | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Canada or Germany?
- Canada, at 80.69 deaths per 100,000 people against 79.01 deaths per 100,000 people in Germany as of 2021.
- What is the difference in death rate from alzheimer's between Canada and Germany?
- 1.68 deaths per 100,000 people, with Canada ahead.
- How many years of comparable data are there for Canada and Germany?
- 22 years are reported by both, from 2000 to 2021.
- How do Canada and Germany rank globally for death rate from alzheimer's?
- Canada ranks 10th and Germany ranks 11th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.